Interpretable Multiple Myeloma Prognosis with Observational Medical Outcomes Partnership Data

arXiv cs.LG / 2026/3/24

💬 オピニオンIdeas & Deep AnalysisModels & Research

要点

  • The paper addresses the adoption barrier in healthcare by proposing regularization methods that make machine-learning survival models more interpretable when trained on real-world clinical data.
  • It develops two penalty-term constructions: one aligns model outputs with an interpretable logistic regression using manually selected features, and the other enforces consistency with the revised international staging system (R-ISS).
  • The study focuses on predicting five-year survival for multiple myeloma patients using data from Helsinki University Hospital.
  • Experiments on 812 patients show the approach can reach test accuracy up to 0.721, and SHAP analyses indicate the models primarily depend on the intended important clinical features.

Abstract

Machine learning (ML) promises better clinical decision-making, yet opaque model behavior limits the adoption in healthcare. We propose two novel regularization techniques for ensuring the interpretability of ML models trained on real-world data. In particular, we consider the prediction of five-year survival for multiple myeloma patients using clinical data from Helsinki University Hospital. To ensure the interpretability of the trained models, we use two alternative constructions for a penalty term used for regularization. The first one penalizes deviations from the predictions obtained from an interpretable logistic regression method with two manually chosen features. The second construction requires consistency of model predictions with the revised international staging system (R-ISS). We verify the usefulness of the proposed regularization techniques in numerical experiments using data from 812 patients. They achieve an accuracy up to 0.721 on a test set and SHAP values show that the models rely on the selected important features.

Interpretable Multiple Myeloma Prognosis with Observational Medical Outcomes Partnership Data | AI Navigate